Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRGO: Perrigo Company -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (4)	10/29/2003 10:40:39 AM
From: Fuzzy	Read Replies (1) \| Respond to of 6

Perrigo Company Extends Share Repurchase Program Wednesday October 29, 8:52 am ET ALLEGAN, Mich., Oct. 29 /PRNewswire-FirstCall/ -- The Perrigo Company (Nasdaq: PRGO - News) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share repurchase program. As of October 21, 2003, Perrigo had 69,872,968 common shares outstanding. ADVERTISEMENT Under share repurchase authorizations since November 2000, Perrigo has repurchased approximately six million shares at a cost of approximately $67 million. Perrigo Company is the nation's largest manufacturer of over-the-counter (non-prescription) pharmaceutical and nutritional products sold by supermarket, drug, and mass merchandise chains under their own labels. The Company's products include over-the-counter pharmaceuticals such as analgesics, cough and cold remedies, gastrointestinal, and feminine hygiene products, and nutritional products, such as vitamins, nutritional supplements and nutritional drinks